However, in the light of the anti-inflammatory role and oncogenic roles of TGR5 and STAT3, respectively, we thus investigated the hitherto unexplored probable oncogenic role of TGR5 and its modulation of the JAK2/STAT3 signaling in HCC progression and prognosis. This evidence concerns the gene JAK2 and hepatocellular carcinoma.